U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula 2Fe.2O4S.3H2O
Molecular Weight 357.861
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS SULFATE SESQUIHYDRATE

SMILES

O.O.O.[Fe++].[Fe++].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O

InChI

InChIKey=JJUUPAANEJLKEY-UHFFFAOYSA-J
InChI=1S/2Fe.2H2O4S.3H2O/c;;2*1-5(2,3)4;;;/h;;2*(H2,1,2,3,4);3*1H2/q2*+2;;;;;/p-4

HIDE SMILES / InChI

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula O4S
Molecular Weight 96.063
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Fe
Molecular Weight 55.845
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3541174 | https://books.google.ru/books?id=7mxyBgAAQBAJ&pg=PA13&lpg=PA13&dq=%22ferrous+iodide%22+anemia&source=bl&ots=ZGyFhUiJZ4&sig=IZOhRVaGmlwX7GcqgoE6rnCsCa4&hl=ru&sa=X&ved=0ahUKEwjYu7PCyYHUAhWiQpoKHR6cCfcQ6AEIUjAJ#v=onepage&q=%22ferrous%20iodide%22&f=false

There is no information about biological and pharmacological application of Iron(II) fluoride (also known as ferrous fluoride). It is known, that this substance is used to catalyze some organic reactions.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
Curative
RADIOGARDASE

Approved Use

Insoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination.

Launch Date

2003
PubMed

PubMed

TitleDatePubMed
FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS.
1932 Nov 11
Tolerability of different oral iron supplements: a systematic review.
2013 Apr
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts.
2014
Atomic Layer Deposition of Iron Sulfide and Its Application as a Catalyst in the Hydrogenation of Azobenzenes.
2017 Mar 13
Patents

Sample Use Guides

Adults should usually take one capsule a day. In cases of pronounced iron deficiency, adults can be given a dosage 2 to 3 times higher at the beginning of therapy. A daily dose of more than 5 mg Fe2+/kg body weight should in-well founded exceptional cases not be exceeded.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:55:34 GMT 2025
Edited
by admin
on Mon Mar 31 21:55:34 GMT 2025
Record UNII
1OA214846O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FERROUS SULFATE SESQUIHYDRATE
Common Name English
FERROHEMATOGEN
Preferred Name English
FERROUS SULPHATE SESQUIHYDRATE
Common Name English
TARDYFERON
Brand Name English
Code System Code Type Description
PUBCHEM
90478523
Created by admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
PRIMARY
CAS
13463-43-9
Created by admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
NON-SPECIFIC STOICHIOMETRY
EVMPD
SUB30109
Created by admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
PRIMARY
FDA UNII
1OA214846O
Created by admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
PRIMARY
DRUG BANK
DBSALT002668
Created by admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
PRIMARY
SMS_ID
100000092908
Created by admin on Mon Mar 31 21:55:34 GMT 2025 , Edited by admin on Mon Mar 31 21:55:34 GMT 2025
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
Related Record Type Details
ACTIVE MOIETY